MSB 1.86% $1.32 mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,261 Posts.
    lightbulb Created with Sketch. 590

    not sure to me but why wasn''t the last trial good enough to an approval process? why another phrase 3 ?

    so we will have 12months trial ?.... but thats from the start time it may take time to get a cohort?
    maybe they can use past patients? would be great to see what happens in a follow up injection, and could it be done in Europe too?

    so more that 12 months wait, then to get data looked at 6 months more...so could end up 2 years before getting back to FDA...

    have i got any of that off the mark?

    can we get some sort of approval to use along the way... Emergency Use, with Opiod epidemic

    i supposse good news for now
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.